Report a pregnancy exposure -Healthcare Provider

Report a pregnancy exposure

Medication Guide
Prescribing Information

Do not administer VERQUVO® (vericiguat) to a pregnant female because it may cause fetal harm and is contraindicated during pregnancy. Advise females of reproductive potential to use effective contraception during treatment and for one month after the final dose. Healthcare Providers should report any prenatal exposure to VERQUVO by calling 1-877-888-4231 or by filling out the form below.

Healthcare Providers in the United States (U.S.) should report an exposure to VERQUVO during pregnancy by:

Contacting Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. at 1-877-888-4231


Entering contact information below to receive a callback within 1 business day to provide information regarding the pregnancy exposure.

Healthcare Providers outside of the U.S., should contact their local MSD office.

* Fields marked with an asterisk are required to be completed to receive a callback.

* Are you reporting a patient was exposed to VERQUVO during pregnancy?(Required)

For other inquiries, please contact Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. at 1-800-672-6372

Please provide your name and phone number:

Please provide your patient’s name and contact phone number:

To report an adverse event or product quality complaint in the U.S., please contact the company at 1-800-672-6372. If you are outside the U.S., please contact your local MSD office.

Privacy Notice

By completing this form and submitting your contact information, you agree that the Company may contact you to gather information regarding an exposure to VERQUVO during pregnancy. The information you provide will be used only for pregnancy exposure reporting purposes, and will not be used for any other purpose unless authorized by you. See the Company’s full Privacy Statement.

Use of Cookies

This site uses Strictly Necessary and Functional cookies to ensure the site operates as intended. These cookies are first party cookies, end with the session, and are exempted from consent. In addition, this site uses Performance cookies solely for quality assurance purposes to satisfy our requirement to reconcile the details you enter on this website and what is received by the Company’s team administering the Pregnancy Surveillance Program.